A Phase 2 Study in Patients With Moderate-to-Severe Psoriasis

Update Il y a 5 ans
Reference: EUCTR2010-018948-14

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

The primary objective of this study is to test the hypothesis that at least 1 LY2439821 treatment group is superior to placebo in the proportion of adult patients with moderate-to-severe chronic plaque psoriasis who achieve a 75% improvement from baseline to Week 12 in the Psoriasis Area and Severity Index (PASI 75) and to estimate the percentage PASI improvement by treatment using regression techniques.


Inclusion criteria

  • Patients With Moderate-To-Severe Psoriasis

Links